Azasan (Salix Pharmaceuticals)
Welcome to the PulseAid listing for the Azasan drug offered from Salix Pharmaceuticals. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Purine Antimetabolite [EPC],Purines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Salix Pharmaceuticals |
| NON-PROPRIETARY NAME: | Azathioprine |
| SUBSTANCE NAME: | AZATHIOPRINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Purine Antimetabolite [EPC],Purines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-04-01 |
| END MARKETING DATE: | 0000-00-00 |
Azasan HUMAN PRESCRIPTION DRUG Details:
| Item Description | Azasan from Salix Pharmaceuticals |
| LABELER NAME: | Salix Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/1) |
| START MARKETING DATE: | 2003-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65649-231_23b999d6-ce52-15a9-e054-00144ff88e88 |
| PRODUCT NDC: | 65649-231 |
| APPLICATION NUMBER: | ANDA075252 |
Other AZATHIOPRINE Pharmaceutical Manufacturers / Labelers:
